Fagron Acquires Purifarma (Brazil)

Fagron Acquires Purifarma in Brazil

January 6, 2026

Pharmaceuticals

Fagron has completed the acquisition of Purifarma, a large-scale pharmaceutical essentials business in Brazil, for an enterprise value of approximately R$250 million. The deal strengthens Fagron's scale and procurement position in Latin America and supports the Group's buy-and-build strategy to expand its pharmaceutical compounding and essentials platform.

PerkinElmer Acquires Project Farma from Precision for Medicine

March 11, 2025

Healthcare Services

PerkinElmer has acquired Project Farma, a life‑sciences technical operations consultancy and subsidiary of Precision for Medicine, to expand its OneSource professional services offering. The acquisition brings Project Farma’s engineering, commissioning/qualification, project management and GMP facility experience into PerkinElmer’s lab services portfolio; terms were not disclosed.

BRANDED Group Acquires Puracy

October 6, 2021

Consumer Products

BRANDED Group has completed the full acquisition of Puracy, a plant-based household cleaning and personal care brand founded in 2013. The deal pairs Puracy's natural-product portfolio and founder team with BRANDED's e-commerce infrastructure and resources to accelerate brand growth and global expansion.

Adragos Pharma Acquires Baccinex

February 6, 2025

Pharmaceuticals

Adragos Pharma, a Munich-headquartered CDMO, has acquired Baccinex, a Swiss sterile fill-finish specialist based in Courroux, Jura. The acquisition adds a US FDA- and EU-GMP-certified 6,200 m² facility and over 110 sterile fill-finish experts to Adragos' global manufacturing network, enhancing its clinical and commercial sterile manufacturing capabilities.

Precision Medicine Group Acquires Project Farma

January 14, 2021

Healthcare Services

Precision Medicine Group has acquired Project Farma, a bioengineering services firm specializing in biomanufacturing strategy and facility implementation with a focus on cell and gene therapies. The deal brings Project Farma's manufacturing and scale-up expertise into Precision's cell and gene therapy services (Precision ADVANCE) to expand end-to-end development, manufacturing, and commercialization capabilities.

Ampersand Capital Partners Acquires Purna Pharmaceuticals

February 12, 2026

Pharmaceuticals

Ampersand Capital Partners acquired Purna Pharmaceuticals, a Belgian contract development and manufacturing provider of liquid and semi-solid pharmaceutical dosage forms. The investment positions Purna to collaborate with Ampersand portfolio company MedPharm to create a trans‑Atlantic topical and transdermal development and manufacturing offering; Creafund, Purna's prior investor, supported the company for more than a decade and was referenced in the transaction announcement.